Exhibit 99.2

Q4 FY13 Question & Answer

June 27, 2013

Consumer Foods organic volume increased 3%.

Commercial Foods volume was flat.

Approximately $146 million (versus approximately $95 million in Q4 FY12).

Approximately $445 million (versus approximately $372 million in FY12).

Approximately $169 million (versus approximately $98 million in Q4 FY12).

1

Approximately $458 million (versus approximately $337 million in FY12).

Approximately $102 million (versus approximately $51 million in Q4 FY12); the increase reflects the incremental interest related to the debt incurred to fund acquisitions, principally Ralcorp.

Approximately $276 million (versus approximately $204 million in FY12); the increase reflects the incremental interest related to the debt incurred to fund acquisitions, principally Ralcorp.

Unallocated Corporate expense was $174 million in the current quarter and $513 million in the year-ago period. Current-quarter amounts include $37 million of unfavorable hedge-related impact and $51 million of net expense from other items impacting comparability. Year-ago period amounts include $53 million of unfavorable hedge-related impact and $397 million of expense related to pension accounting changes. Excluding these amounts, unallocated Corporate expense was $86 million for the current quarter and $64 million in the year-ago period. The comparable increase largely reflects higher incentives and the addition of Ralcorp corporate expense.

Approximately $104 million (versus approximately $100 million in Q4 FY12), reflecting an increase in shares outstanding and a higher dividend rate.

Approximately $401 million.

Approximately 426 million shares for the quarter; approximately 418 million shares for the full fiscal year.

No, the company did not repurchase any shares during the quarter.

2

Gross margin = segment gross profit* divided by net sales

Gross margin = $1,001/$4,594 = 22%

Operating margin = segment operating profit** divided by net sales

Operating margin = $555/$4,594 = 12%

The net-debt-to-total-capital ratio for the quarter was 64%.

This ratio is defined as net debt divided by the sum of net debt plus shareholders’ equity. See question No. #16 for the components of net debt.

The effective tax rate for the fourth quarter and the full fiscal year was 32% and 34%, respectively, in line with the company’s expectations.

The company expects the tax rate to be in the range of 33-34%, excluding items impacting comparability. The company acknowledges that the quarterly rates may be different from this, given the timing of certain matters, but that the overall rate is expected to approximate 33-34%.

Total capital expenditures for fiscal 2014 are projected to be approximately $650 million.

Total depreciation and amortization for fiscal 2014 is projected to be approximately $600 million.

3

Net interest expense for fiscal 2014 is projected to be approximately $410 million.

4

Note on Forward-looking Statements

This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations and are subject to uncertainty and changes in circumstances. These risks and uncertainties include, among other things: ConAgra Foods’ ability to realize the synergies and benefits contemplated by the acquisition of Ralcorp and its ability to promptly and effectively integrate the business of Ralcorp; the timing to consummate the potential joint venture combining the flour milling businesses of ConAgra Foods, Cargill, and CHS; ConAgra Foods’ ability to realize the synergies and benefits contemplated by the potential joint venture; availability and prices of raw materials, including any negative effects caused by inflation or adverse weather conditions; the effectiveness of ConAgra Foods’ product pricing, including any pricing actions and promotional changes; future economic circumstances; industry conditions; ConAgra Foods’ ability to execute its operating and restructuring plans; the success of ConAgra Foods’ innovation, marketing, including increased marketing investments, and cost-saving initiatives; the competitive environment and related market conditions; operating efficiencies; the ultimate impact of any ConAgra Foods product recalls; access to capital; ConAgra Foods’ success in efficiently and effectively integrating its acquisitions; actions of governments and regulatory factors affecting ConAgra Foods’ businesses, including the Patient Protection and Affordable Care Act; the amount and timing of repurchases of ConAgra Foods’ common stock, if any; and other risks described in ConAgra Foods’ reports filed with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent reports on Forms 10-Q and 8-K. Investors and security holders are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. ConAgra Foods disclaims any obligation to update or revise statements contained in this document to reflect future events or circumstances or otherwise.

5